Compound 168
Identifiers
- Canonical SMILES:
OC(=O)c1csc(n1)-c1ccc2CCCN(C(=O)Nc3nc4ccccc4s3)c2c1
- IUPAC name:
2-[1-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-2H-quinolin-7-yl]-1,3-thiazole-4-carboxylic acid
- InChi:
InChI=1S/C21H16N4O3S2/c26-19(27)15-11-29-18(22-15)13-8-7-12-4-3-9-25(16(12)10-13)21(28)24-20-23-14-5-1-2-6-17(14)30-20/h1-2,5-8,10-11H,3-4,9H2,(H,26,27)(H,23,24,28)
- InChiKey:
MPBQJXNTYAFDCG-UHFFFAOYSA-N
External links
46840791 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.71 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 436.07 g/mol | |||
HBA | 7 | |||
HBD | 2 | |||
HBA + HBD | 9 | |||
AlogP | 5.02 | |||
TPSA | 95.42 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2010080478 | 1 | BCL2 P10415 |
|
Biochemical assay | Time-Resolved FRET | pKi (inhibition constant, -log10) | 5.92 | |
WO2010080478 | 1 | B2CL2 Q92843 |
|
Biochemical assay | Time-Resolved FRET | pKi (inhibition constant, -log10) | 6.71 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4688 | Tozadenant | DB12203 | |
0.4460 | 4SC-203 | DB12669 | |
0.4326 | 1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea | DB07362 | |
0.4307 | 1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea | DB07360 | |
0.4281 | SAR-125844 | DB15382 | |
0.4137 | Alpelisib | DB12015 | |
0.4132 | (S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE | DB07792 | |
0.4128 | (4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE | DB07406 | |
0.4116 | 2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE | DB07066 | |
0.4060 | 2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID | DB08657 | |
0.4059 | Talarozole | DB13083 | |
0.4043 | Lintitript | DB04867 | |
0.4000 | SRT-2104 | DB12186 | |
0.3986 | SNS-314 | DB06134 | |
0.3891 | Snubh-nm-333 F-18 | DB15457 |